1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Life science AI and machine learning Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Life science AI and machine learning Market, by Product Type
8.1.1. AI Analytics Platform
8.1.1.1. Market Revenue and Forecast
8.1.2. Machine Learning Software Tools
8.1.2.1. Market Revenue and Forecast
8.1.3. AI-Integrated Imaging & Diagnostics Systems
8.1.3.1. Market Revenue and Forecast
8.1.4. Bioinformatics & Computational Biology Platforms
8.1.4.1. Market Revenue and Forecast
8.1.5. Ancillary Tools & Accessories
8.1.5.1. Market Revenue and Forecast
9.1. Life science AI and machine learning Market, by Deployment Type
9.1.1. On-Premise
9.1.1.1. Market Revenue and Forecast
9.1.2. Cloud-Based
9.1.2.1. Market Revenue and Forecast
9.1.3. Hybrid
9.1.3.1. Market Revenue and Forecast
10.1. Life science AI and machine learning Market, by Application
10.1.1. Drug Discovery & Development
10.1.1.1. Market Revenue and Forecast
10.1.2. Genomics & Precision Medicine
10.1.2.1. Market Revenue and Forecast
10.1.3. Medical Imaging & Diagnostics
10.1.3.1. Market Revenue and Forecast
10.1.4. Clinical Trial Optimization
10.1.4.1. Market Revenue and Forecast
10.1.5. Other Life Science Applications
10.1.5.1. Market Revenue and Forecast
11.1. Life science AI and machine learning Market, by Technology / Mode of Action
11.1.1. Machine Learning Algorithms
11.1.1.1. Market Revenue and Forecast
11.1.2. Deep Learning / Neural Networks
11.1.2.1. Market Revenue and Forecast
11.1.3. Computer Vision-Based Analysis
11.1.3.1. Market Revenue and Forecast
11.1.4. Analog, MEMS and Others
11.1.4.1. Market Revenue and Forecast
11.1.5. Natural Language Processing (NLP)
11.1.5.1. Market Revenue and Forecast
12.1. Life science AI and machine learning Market, by End-User
12.1.1. Pharmaceutical & Biotech Companies
12.1.1.1. Market Revenue and Forecast
12.1.2. Hospitals & Clinical Labs
12.1.2.1. Market Revenue and Forecast
12.1.3. Foundries
12.1.3.1. Market Revenue and Forecast
12.1.4. Academic & Research Institutes
12.1.4.1. Market Revenue and Forecast
12.1.5. CROs / Clinical Research Organizations
12.1.5.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product Type
13.1.2. Market Revenue and Forecast, by Deployment Type
13.1.3. Market Revenue and Forecast, by Application
13.1.4. Market Revenue and Forecast, by Technology / Mode of Action
13.1.5. Market Revenue and Forecast, by End-User
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product Type
13.1.6.2. Market Revenue and Forecast, by Deployment Type
13.1.6.3. Market Revenue and Forecast, by Application
13.1.6.4. Market Revenue and Forecast, by Technology / Mode of Action
13.1.6.5. Market Revenue and Forecast, by End-User
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product Type
13.1.7.2. Market Revenue and Forecast, by Deployment Type
13.1.7.3. Market Revenue and Forecast, by Application
13.1.7.4. Market Revenue and Forecast, by Technology / Mode of Action
13.1.7.5. Market Revenue and Forecast, by End-User
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product Type
13.2.2. Market Revenue and Forecast, by Deployment Type
13.2.3. Market Revenue and Forecast, by Application
13.2.4. Market Revenue and Forecast, by Technology / Mode of Action
13.2.5. Market Revenue and Forecast, by End-User
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product Type
13.2.6.2. Market Revenue and Forecast, by Deployment Type
13.2.6.3. Market Revenue and Forecast, by Application
13.2.7. Market Revenue and Forecast, by Technology / Mode of Action
13.2.8. Market Revenue and Forecast, by End-User
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product Type
13.2.9.2. Market Revenue and Forecast, by Deployment Type
13.2.9.3. Market Revenue and Forecast, by Application
13.2.10. Market Revenue and Forecast, by Technology / Mode of Action
13.2.11. Market Revenue and Forecast, by End-User
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product Type
13.2.12.2. Market Revenue and Forecast, by Deployment Type
13.2.12.3. Market Revenue and Forecast, by Application
13.2.12.4. Market Revenue and Forecast, by Technology / Mode of Action
13.2.13. Market Revenue and Forecast, by End-User
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product Type
13.2.14.2. Market Revenue and Forecast, by Deployment Type
13.2.14.3. Market Revenue and Forecast, by Application
13.2.14.4. Market Revenue and Forecast, by Technology / Mode of Action
13.2.15. Market Revenue and Forecast, by End-User
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product Type
13.3.2. Market Revenue and Forecast, by Deployment Type
13.3.3. Market Revenue and Forecast, by Application
13.3.4. Market Revenue and Forecast, by Technology / Mode of Action
13.3.5. Market Revenue and Forecast, by End-User
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product Type
13.3.6.2. Market Revenue and Forecast, by Deployment Type
13.3.6.3. Market Revenue and Forecast, by Application
13.3.6.4. Market Revenue and Forecast, by Technology / Mode of Action
13.3.7. Market Revenue and Forecast, by End-User
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product Type
13.3.8.2. Market Revenue and Forecast, by Deployment Type
13.3.8.3. Market Revenue and Forecast, by Application
13.3.8.4. Market Revenue and Forecast, by Technology / Mode of Action
13.3.9. Market Revenue and Forecast, by End-User
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product Type
13.3.10.2. Market Revenue and Forecast, by Deployment Type
13.3.10.3. Market Revenue and Forecast, by Application
13.3.10.4. Market Revenue and Forecast, by Technology / Mode of Action
13.3.10.5. Market Revenue and Forecast, by End-User
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product Type
13.3.11.2. Market Revenue and Forecast, by Deployment Type
13.3.11.3. Market Revenue and Forecast, by Application
13.3.11.4. Market Revenue and Forecast, by Technology / Mode of Action
13.3.11.5. Market Revenue and Forecast, by End-User
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product Type
13.4.2. Market Revenue and Forecast, by Deployment Type
13.4.3. Market Revenue and Forecast, by Application
13.4.4. Market Revenue and Forecast, by Technology / Mode of Action
13.4.5. Market Revenue and Forecast, by End-User
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product Type
13.4.6.2. Market Revenue and Forecast, by Deployment Type
13.4.6.3. Market Revenue and Forecast, by Application
13.4.6.4. Market Revenue and Forecast, by Technology / Mode of Action
13.4.7. Market Revenue and Forecast, by End-User
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product Type
13.4.8.2. Market Revenue and Forecast, by Deployment Type
13.4.8.3. Market Revenue and Forecast, by Application
13.4.8.4. Market Revenue and Forecast, by Technology / Mode of Action
13.4.9. Market Revenue and Forecast, by End-User
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product Type
13.4.10.2. Market Revenue and Forecast, by Deployment Type
13.4.10.3. Market Revenue and Forecast, by Application
13.4.10.4. Market Revenue and Forecast, by Technology / Mode of Action
13.4.10.5. Market Revenue and Forecast, by End-User
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product Type
13.4.11.2. Market Revenue and Forecast, by Deployment Type
13.4.11.3. Market Revenue and Forecast, by Application
13.4.11.4. Market Revenue and Forecast, by Technology / Mode of Action
13.4.11.5. Market Revenue and Forecast, by End-User
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product Type
13.5.2. Market Revenue and Forecast, by Deployment Type
13.5.3. Market Revenue and Forecast, by Application
13.5.4. Market Revenue and Forecast, by Technology / Mode of Action
13.5.5. Market Revenue and Forecast, by End-User
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product Type
13.5.6.2. Market Revenue and Forecast, by Deployment Type
13.5.6.3. Market Revenue and Forecast, by Application
13.5.6.4. Market Revenue and Forecast, by Technology / Mode of Action
13.5.7. Market Revenue and Forecast, by End-User
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product Type
13.5.8.2. Market Revenue and Forecast, by Deployment Type
13.5.8.3. Market Revenue and Forecast, by Application
13.5.8.4. Market Revenue and Forecast, by Technology / Mode of Action
13.5.8.5. Market Revenue and Forecast, by End-User
14.1. IBM Watson Health
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Google DeepMind / Google Life Sciences (Verily)
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Microsoft Healthcare AI
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. NVIDIA Corporation
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Amazon Web Services (AWS) AI/ML for Life Sciences
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. SAS Institute
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. IQVIA
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Thermo Fisher Scientific
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Illumina AI Platforms
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Roche Diagnostics AI Solutions
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client